VeriChip Corporation Announces $10 Million Financing Commitment
29 Septiembre 2009 - 10:46AM
Business Wire
VeriChip Corporation ("VeriChip" or the "Company") (NASDAQ:
CHIP) today announced it has entered into a definitive agreement
for a $10,000,000 investment commitment with Optimus Technology
Capital Partners, LLC, or Optimus. The Company expects to use a
portion of the proceeds to fund its development programs with
RECEPTORS LLC to develop a virus triage detection system for the
H1N1 virus and an in vivo glucose-sensing RFID microchip. The
Company will use the remainder of the funds for working capital and
general corporate purposes.
Scott R. Silverman, Chairman and CEO of VeriChip, stated, "This
financing arrangement was established at terms we believe are very
favorable to the Company. Importantly, this financing, when
completed, fully funds our development partnerships with RECEPTORS
for both the virus triage detection system and glucose-sensing RFID
microchip, and provides funds for additional working capital."
The Company may issue convertible preferred shares from time to
time in multiple tranches. The preferred will accrue a 10% in kind
dividend and provides an option for the Company to prepay with a
make-whole premium. The tranches will be convertible into
restricted common stock at the market price on the date of each
tranche. In conjunction with the financing, R & R Consulting
Partners, LLC, which is controlled by Mr. Silverman, agreed to
enter into one or more Stock Loan Agreements with Optimus to
facilitate the transaction. The financing is subject to customary
closing conditions. The Company plans to file a Form 8-K to provide
more details of the financing.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida,
has developed the VeriMed™ Health Link System for rapidly and
accurately identifying people who arrive in an emergency room and
are unable to communicate. This system uses the first
human-implantable passive RFID microchip and corresponding personal
health record, cleared for medical use in October 2004 by the
United States Food and Drug Administration.
On September 8, 2009, VeriChip Corporation announced it agreed
to acquire Steel Vault Corporation (OTCBB: SVUL) to form PositiveID
Corporation. PositiveID will provide identification technologies
and tools to protect consumers and businesses. The companies expect
the merger to close in the fourth quarter of 2009.
For more information on VeriChip, please call 1-800-970-2447, or
e-mail info@verichipcorp.com. Additional information can be found
online at www.verichipcorp.com.
Statements about VeriChip’s future expectations, including its
ability to fund and develop a triage detection system for detection
of the H1N1 virus and an in vivo glucose-sensing microchip, the
expectation that Optimus will purchase preferred stock from the
Company, the expectation that the company will use a portion of the
proceeds to fund its development programs with RECEPTORS LLC to
develop a virus triage detection system for the H1N1 virus and an
in vivo glucose-sensing RFID microchip and use the remainder of the
funds for working capital and general corporate purposes and all
other statements in this press release other than historical facts
are “forward-looking statements” within the meaning of Section 27A
of the Securities Act of 1933, Section 21E of the Securities
Exchange Act of 1934, and as that term is defined in the Private
Litigation Reform Act of 1995. Such forward-looking statements
involve risks and uncertainties and are subject to change at any
time, and VeriChip’s actual results could differ materially from
expected results. These risks and uncertainties include without
limitation, the inability to fully fund the financing due to the
failure to obtain stockholder approval as may be required; the
failure of the Company to meet the funding conditions set forth in
the agreement with Optimus; the impact of, and restrictions
associated with, the debt incurred in connection with the
transaction; transaction costs being greater than anticipated;
unanticipated delays as a result of regulatory issues or other
factors; and changes in economic conditions. Additional information
about these and other factors that could affect the Company’s
business is set forth in the Company’s various filings with the
Securities and Exchange Commission, including those set forth in
the Company’s 10-K filed on February 12, 2009, under the caption
“Risk Factors.” The Company undertakes no obligation to update or
release any revisions to these forward-looking statements to
reflect events or circumstances after the date of this statement or
to reflect the occurrence of unanticipated events, except as
required by law.
Additional Information and Where to Find It
On September 8, 2009, VeriChip and Steel Vault issued a joint
press release announcing the signing of an Agreement and Plan of
Reorganization, among VeriChip, Steel Vault and VeriChip
Acquisition Corp., a Delaware corporation and wholly-owned
subsidiary of VeriChip (the “Acquisition Subsidiary”), pursuant to
which the Acquisition Subsidiary will be merged with and into Steel
Vault, with Steel Vault surviving and becoming a wholly-owned
subsidiary of VeriChip (the “Merger”). Upon the consummation of the
Merger, each outstanding share of Steel Vault’s common stock will
be converted into 0.5 shares of VeriChip common stock.
In connection with the Merger, VeriChip filed with the
Securities and Exchange Commission (“SEC”) a Registration Statement
on Form S-4 that will contain a Joint Proxy Statement/Prospectus of
VeriChip and Steel Vault. Investors and security holders are urged
to read the Registration Statement and the Joint Proxy
Statement/Prospectus carefully because they contain important
information about VeriChip, Steel Vault and the proposed
transaction. The Joint Proxy Statement/Prospectus and other
relevant materials (when they become available), and any other
documents filed with the SEC, may be obtained free of charge at the
SEC’s web site (www.sec.gov). In addition, investors and security
holders may obtain a free copy of other documents filed by VeriChip
or Steel Vault by directing a written request, as appropriate, to
VeriChip at 1690 South Congress Avenue, Suite 200 Delray Beach,
Florida 33445, Attention: Investor Relations, or to Steel Vault at
1690 South Congress Avenue, Suite 200 Delray Beach, Florida 33445,
Attention: Investor Relations. Investors and security holders are
urged to read the Joint Proxy Statement/Prospectus and the other
relevant materials before making any voting or investment decision
with respect to the proposed transaction.
VeriChip, Steel Vault and their respective directors and
executive officers may be deemed to be participants in the
solicitation of proxies in connection with the proposed
transaction.
Information regarding the interests of these directors and
executive officers in the proposed transaction will be included in
the Joint Proxy Statement/Prospectus referred to above. Additional
information regarding the directors and executive officers of
VeriChip is also included in VeriChip's Form 10-K, which was filed
with the SEC on February 12, 2009. Additional information regarding
the directors and executive officers of Steel Vault is also
included in Steel Vault's proxy statement (Form DEF 14A) for
the 2009 annual meeting of Steel Vault's stockholders, which was
filed with the SEC on February 9, 2009, as amended. These documents
are available free of charge at the SEC’s website (www.sec.gov) and
by contacting Investor Relations at the addresses above.
Verichip (MM) (NASDAQ:CHIP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Verichip (MM) (NASDAQ:CHIP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024